tradingkey.logo
tradingkey.logo
Search

Edwards Lifesciences Corp

EW
Add to Watchlist
89.070USD
-1.020-1.13%
Close 10-23 16:00(ET)
51.34BMarket Cap
47.33P/E TTM
After-hours 19:00 (ET)89.070USD-0.090-0.10%

Edwards Lifesciences Corp (EW) Revenue Performance

Updated: Jun 30, 2026

Last year, Edwards Lifesciences Corp generated 4.49B USD for its biggest-performing segment, Transcatheter Aortic Valve Replacement. The United States made the largest contribution, accounting for 3.54B USD last year. For the latest quarter, Edwards Lifesciences Corp reported the revenue of 1.26B USD for the period ending 2026-06-30, which came from the top-performing segment, Transcatheter Aortic Valve Replacement. United States contributed the highest revenue, at 1.00B USD.

By Business

Annual
Annual
Quarterly
Transcatheter Aortic Valve Replacement
Surgical Heart Valve Therapy
Transcatheter Mitral and Tricuspid Therapies
Critical Care
Transcatheter Heart Valve Therapy
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Transcatheter Aortic Valve Replacement
4.49B(73.96%)
4.11B(75.49%)
3.88B(65.34%)
3.52B(66.14%)
3.42B(65.41%)
2.86B(65.14%)
2.74B(62.97%)
--(--)
--(--)
--(--)
--(--)
Surgical Heart Valve Therapy
1.03B(16.96%)
981.30M(18.04%)
932.60M(15.71%)
829.70M(15.60%)
889.10M(16.99%)
761.80M(17.37%)
841.70M(19.36%)
761.60M(20.46%)
807.10M(23.49%)
774.90M(26.15%)
785.00M(31.48%)
Transcatheter Mitral and Tricuspid Therapies
550.60M(9.07%)
352.10M(6.47%)
197.60M(3.33%)
116.10M(2.18%)
86.00M(1.64%)
41.80M(0.95%)
28.20M(0.65%)
--(--)
--(--)
--(--)
--(--)
Critical Care
--(--)
--(--)
928.10M(15.63%)
855.00M(16.07%)
834.90M(15.96%)
725.40M(16.54%)
740.20M(17.02%)
674.50M(18.12%)
601.00M(17.49%)
560.30M(18.91%)
528.40M(21.19%)
Transcatheter Heart Valve Therapy
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
2.29B(61.42%)
2.03B(59.01%)
1.63B(54.95%)
1.18B(47.33%)

By Region

Annual
Annual
Quarterly
United States
Europe
Rest of the world
Japan
Unallocated
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
United States
3.54B(58.39%)
3.21B(58.94%)
2.95B(58.84%)
2.63B(58.88%)
2.96B(56.63%)
2.52B(57.38%)
2.53B(58.25%)
Europe
1.52B(25.01%)
1.32B(24.30%)
1.18B(23.56%)
1.04B(23.30%)
1.19B(22.75%)
945.20M(21.55%)
926.10M(21.30%)
Rest of the world
652.30M(10.75%)
572.00M(10.52%)
531.10M(10.60%)
436.00M(9.77%)
550.20M(10.52%)
451.50M(10.29%)
433.30M(9.97%)
Japan
354.70M(5.85%)
339.80M(6.25%)
350.80M(7.00%)
359.50M(8.05%)
528.90M(10.11%)
448.60M(10.23%)
441.40M(10.15%)
Unallocated
--(--)
--(--)
--(--)
--(--)
--(--)
24.20M(0.55%)
14.50M(0.33%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.